Company Oramed Pharmaceuticals Inc. Deutsche Boerse AG
Equities
OJU1
US68403P2039
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.404 EUR | +6.04% |
|
+22.09% | +16.83% |
06-26 | Oramed Pharmaceuticals Board Approves $20 Million Share-Buyback Program | MT |
06-26 | Oramed Pharmaceuticals Inc. announces an Equity Buyback for $20 million worth of its shares. | CI |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Solutions
100.0
%
| 3 | 100.0 % | 1 | 100.0 % | -50.43% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Israel
100.0
%
| 3 | 100.0 % | 1 | 100.0 % | -50.43% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Miriam Kidron
FOU | Founder | 83 | 02-04-11 |
Nadav Kidron
CEO | Chief Executive Officer | 50 | 02-04-11 |
Joshua Hexter
COO | Chief Operating Officer | 53 | 13-04-13 |
Leonard Sank
BRD | Director/Board Member | 59 | 07-10-22 |
Zach Herschfus
IRC | Investor Relations Contact | - | - |
Netanel Derovan
LAW | General Counsel | - | 22-01-08 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Nadav Kidron
CEO | Chief Executive Officer | 50 | 02-04-11 |
Miriam Kidron
FOU | Founder | 83 | 02-04-11 |
Leonard Sank
BRD | Director/Board Member | 59 | 07-10-22 |
Arie Mayer
BRD | Director/Board Member | 67 | 19-12-04 |
Benjamin Shapiro
BRD | Director/Board Member | 40 | 23-04-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 40,628,924 | 35,961,754 ( 88.51 %) | 0 | 88.51 % |
Company contact information
Oramed Pharmaceuticals, Inc.
1185 Avenue of the Americas 3rd Floor
10036, New York
+844 967 2633
http://www.oramed.com![address Oramed Pharmaceuticals Inc.(OJU1)](https://cdn.zonebourse.com/static/address/12416907.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.65% | 39.1B | |
-9.07% | 38.76B | |
+27.15% | 31.24B | |
+11.05% | 25.9B | |
-13.50% | 25.8B | |
+43.87% | 14.06B | |
+34.79% | 13.12B | |
-7.96% | 11.32B | |
-13.11% | 10.68B |
- Stock Market
- Equities
- ORMP Stock
- OJU1 Stock
- Company Oramed Pharmaceuticals Inc.